Antilipemic drugs and the position of the FDA.
D000328:Adult; D001161:Arteriosclerosis / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000178:diet therapy / Q000188:drug therapy; D004341:Drug Evaluation; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D009316:National Institutes of Health (U.S.); D013997:Time Factors; D014044:Tolbutamide / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D014944:World Health Organization
D000960:Hypolipidemic Agents; D007328:Insulin; D014044:Tolbutamide